When: $607-615 (50 SMA/Bollinger mid confluence)

Then: Reserve optional 1%

Stage into 3-4% maximum position with pullback entries rather than full sizing at current elevated levels

• RSI of 73.97 following 25% rally in 30 sessions from 539 to 682 is a warning signal, unlike historical sustained RSI readings that followed multi-month basing patterns
• MACD histogram declining from 10.44 to 9.69 at new highs signals velocity slowing
• Operating income fell from 22.9B to 18.8B while revenue was up sequentially; R&D rose from 17.7B to 21.7B and SG&A surged from 5.5B to 9B (64% QoQ)
• FCF margin at ~9% TTM versus 33% historically; total debt up 127% in 18 months to 112.3B; net debt at 68.2B
• Construction in progress at 80B as physical capex requiring ROI proof
• Zero buybacks in H1 2026 confirmed; insider selling ongoing into elevated prices
• Q3 earnings is binary event risk 4-6 weeks out with no margin of safety at 682
• Consensus bullishness from BofA, Goldman, Motley Fool, Schaeffer's, Barron's in same week indicates sell-side coordination rather than independent confirmation
• Polymarket shows 84% probability of another Fed hike; no cuts at 95%
• META beta of 1.24 means 10% market drawdown equals 12.4% stock drop
• Downside path to 10 EMA at 649 or 50 SMA at 607 more likely than upside to 52-week high of 750-790 in hiking Fed environment
• Proposed staged entry: 1% starter, 1-1.5% at 649-660, 1-1.5% at 607-615

→ vs aggressive: RSI comparison ignores that prior sustained readings followed multi-month basing, not 25% monthly ramps

→ vs aggressive: Q3 earnings is binary event risk, not validation; treating it as certainty when sizing 6-8% is gambling, not conviction

→ vs aggressive: Consensus bullishness creates no margin of safety when narrative is fully priced; coordination on AI theme is not independent confirmation

→ vs aggressive: Patient buyer thesis misframes capital preservation as cost; not buying with stop at 618 preserves capital at zero cost

→ vs aggressive: 52-week high target ignores overhead supply, hiking Fed multiple compression, and sequential catalyst requirements

→ vs aggressive: Macro environment with 84% Fed hike odds cannot be dismissed as irrelevant; assuming AI bid stays supportive is double-counting the bullish scenario

→ vs aggressive: Position sizing of 6-8% with META beta of 1.24 creates 75-100 basis point portfolio exposure to market drawdown alone

BUY with staged deployment: 1.5-2% starter (increased from 1%), 1-1.5% at 649-660, optional third tranche at 607-615, max 3-4% total

• RSI 73.97 coexists with confirmed regime change after 25% ramp in ~13 sessions from major low - velocity fundamentally different from historical RSI 75-85 during basing patterns
• Upside to 750-790 requires: break above upper Bollinger at 699, absorb overhead supply 700-750, navigate hiking Fed with 84% rate increase odds, validate $30B quarterly capex at Q3 earnings - three sequential catalysts needed
• Downside to 649 or 607 requires less friction than upside path; realistic risk-reward ~1:2 at current levels vs 4:1 claimed by aggressive
• 200 SMA reclaim at 623 represents confirmed regime shift from downtrend to recovery - structural technical signal supporting staged deployment framework
• Q2 operating income compression driven by R&D ($17.7B to $21.7B) and SG&A ($5.5B to $9B) spending during AI talent war and infrastructure scaling
• Buyback pause to zero in H1 2026 signals management prioritizing debt-funded capex over shareholder returns at current prices
• Q3 earnings ~4-6 weeks away and Anthropic IPO catalyst in October-November window create near-term binary event risk
• Beta 1.24 with hawkish Fed backdrop elevates concentration risk - 3-4% maximum position appropriately calibrated vs 6-8% aggressive overconcentration
• Consensus broadly bullish from BofA, Goldman, Motley Fool, Schaeffer's, Barron's in same week indicates coordinated sell-side coverage on hot narrative
• Stop at 618 sits below 200 SMA at 623; ATR-based trailing stops at 1x (~661) and 2x (~640) alternatives once position established

→ vs aggressive: RSI 73.97 argument is intellectually dishonest - sustained RSI 75-85 historically occurred after multi-month basing patterns with consolidation, not 25% ramps in 13 sessions; cannot claim regime change AND dismiss overbought momentum reading

→ vs aggressive: Asymmetry math is broken - anchoring on 52-week high at 750-790 without path analysis; requires multiple sequential catalysts vs single negative catalyst for downside

→ vs aggressive: 6-8% position size too aggressive given 1.24 beta, binary Q3 earnings in 4-6 weeks, and hawkish Fed backdrop

→ vs conservative: 200 SMA reclaim framing as just another technical level is too dismissive - this is confirmed structural regime shift from downtrend to recovery

→ vs conservative: Waiting for pullback to 649 ignores probability distribution - path of least resistance tends higher between major catalysts in real markets; capital preservation has opportunity cost

→ vs conservative: Consensus being bullish does not preclude good entries on compounding names - Microsoft cloud, Apple iPhone cycle, Nvidia AI buildout all had bullish consensus

→ vs conservative: Conservative wants to stay on sidelines entirely - wrong call given confirmed regime change and catalyst pipeline; measured exposure is correct